BIM
LUMO

Bogle Investment Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bogle Investment Management’s Portfolio LUMO Stock Details LUMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,216
Closed -$30K – 340
2019
Q2 		$30K Sell
2,216
-345
-13% -$5.21K ﹤0.01% 269
2019
Q1 		$44K Sell
2,561
-3,253
-56% -$48.5K ﹤0.01% 271
2018
Q4 		$80K Sell
5,814
-622
-10% -$11K 0.01% 316
2018
Q3 		$138K Sell
6,436
-521
-7% -$15.8K 0.01% 260
2018
Q2 		$298K Buy
6,957
+299
+4% +$13.7K 0.02% 252
2018
Q1 		$434K Buy
+6,658
New +$472K 0.03% 269
2017
Q3 		– Sell
-49,251
Closed -$3.26M – 364
2017
Q2 		$3.26M Buy
49,251
+47,373
+2,523% +$5.86M 0.24% 124
2017
Q1 		$407K Sell
1,878
-17,686
-90% -$2.53M 0.03% 270
2016
Q4 		$1.81M Sell
19,564
-4,833
-20% -$545K 0.12% 187
2016
Q3 		$3.3M Sell
24,397
-26,730
-52% -$2.65M 0.24% 134
2016
Q2 		$5.18M Buy
51,127
+2,394
+5% +$297K 0.36% 99
2016
Q1 		$7.98M Buy
48,733
+43,449
+822% +$8.81M 0.53% 71
2015
Q4 		$1.73M Sell
5,284
-29,159
-85% -$9.49M 0.12% 210
2015
Q3 		$11.1M Hold
34,443
– – 0.79% 33
2015
Q2 		$13.7M Buy
+34,443
New +$14.6M 1.02% 7

Other funds holding LUMO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Bogle Investment Management's LUMO Position: Q3 2019 in Review

Bogle Investment Management sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q3 2019, closing a stake of 2,216 shares — an estimated $30K sold.

Bogle Investment Management first reported a position in LUMO in Q2 2015 and held it in 15 quarters. The position peaked at $13.7M in Q2 2015. 68 funds tracked by Wall St. Rank hold LUMO as of Q3 2019.

  • Bogle Investment Management reported no remaining Lumos Pharma, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Bogle Investment Management sold 2,216 Lumos Pharma, Inc. Common Stock shares in Q3 2019, an estimated $30K.
  • Bogle Investment Management first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2015 and held it in 15 quarters.
  • Bogle Investment Management's Lumos Pharma, Inc. Common Stock position peaked at $13.7M in Q2 2015.
  • 68 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q3 2019.

Based on Bogle Investment Management's 13F filing for Q3 2019, filed 13 Nov 2019.